A citation-based method for searching scientific literature

J Ferlay, M Colombet, I Soerjomataram, T Dyba, G Randi, M Bettio, A Gavin, O Visser, F Bray. Eur J Cancer 2018
Times Cited: 873

List of co-cited articles
148 articles co-cited >1

Times Cited
  Times     Co-cited

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020

Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Caroline Robert, Jacob Schachter, Georgina V Long, Ana Arance, Jean Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem,[...]. N Engl J Med 2015

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015

International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?
Friederike Erdmann, Joannie Lortet-Tieulent, Joachim Schüz, Hajo Zeeb, Rüdiger Greinert, Eckhard W Breitbart, Freddie Bray. Int J Cancer 2013

Trends in mortality from cutaneous malignant melanoma in Spain (1982-2016): sex-specific age-cohort-period effects.
E Gutiérrez-González, G López-Abente, N Aragonés, M Pollán, R Pastor-Barriuso, M J Sánchez, B Pérez-Gómez. J Eur Acad Dermatol Venereol 2019

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
J Ferlay, E Steliarova-Foucher, J Lortet-Tieulent, S Rosso, J W W Coebergh, H Comber, D Forman, F Bray. Eur J Cancer 2013

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, I Soerjomataram, C Mathers, D M Parkin, M Piñeros, A Znaor, F Bray. Int J Cancer 2019

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
M Ducreux, A Sa Cuhna, C Caramella, A Hollebecque, P Burtin, D Goéré, T Seufferlein, K Haustermans, J L Van Laethem, T Conroy,[...]. Ann Oncol 2015

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.
Peter J Allen, Deborah Kuk, Carlos Fernandez-Del Castillo, Olca Basturk, Christopher L Wolfgang, John L Cameron, Keith D Lillemoe, Cristina R Ferrone, Vicente Morales-Oyarvide, Jin He,[...]. Ann Surg 2017

Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.
M Arnold, C Holterhues, L M Hollestein, J W W Coebergh, T Nijsten, E Pukkala, B Holleczek, L Tryggvadóttir, H Comber, M J Bento,[...]. J Eur Acad Dermatol Venereol 2014

Is melanoma mortality declining in Spain? Analysis of trends from 1975 to 2016.
A Cayuela, L Cayuela, S Rodríguez-Domínguez, A I Lorente, M Rodríguez de la Borbolla. Br J Dermatol 2018

Incidence, mortality and survival in cutaneous melanoma.
A-V Giblin, J M Thomas. J Plast Reconstr Aesthet Surg 2007

Cutaneous malignant melanoma in Europe.
Esther de Vries, Jan Willem Coebergh. Eur J Cancer 2004

Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001.
A Cayuela, S Rodríguez-Domínguez, J Lapetra-Peralta, J S Conejo-Mir. Br J Dermatol 2005

Trends in incidence of thick, thin and in situ melanoma in Europe.
L Sacchetto, R Zanetti, H Comber, C Bouchardy, D H Brewster, P Broganelli, M D Chirlaque, D Coza, J Galceran, A Gavin,[...]. Eur J Cancer 2018

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011

Global Cancer Incidence and Mortality Rates and Trends--An Update.
Lindsey A Torre, Rebecca L Siegel, Elizabeth M Ward, Ahmedin Jemal. Cancer Epidemiol Biomarkers Prev 2016

Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2016

EAU guidelines on renal cell carcinoma: 2014 update.
Borje Ljungberg, Karim Bensalah, Steven Canfield, Saeed Dabestani, Fabian Hofmann, Milan Hora, Markus A Kuczyk, Thomas Lam, Lorenzo Marconi, Axel S Merseburger,[...]. Eur Urol 2015

Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
J H Scholefield, S M Moss, C M Mangham, D K Whynes, J D Hardcastle. Gut 2012

Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. CA Cancer J Clin 2015

Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
David C Grossman, Susan J Curry, Douglas K Owens, Kirsten Bibbins-Domingo, Aaron B Caughey, Karina W Davidson, Chyke A Doubeni, Mark Ebell, John W Epling, Alex R Kemper,[...]. JAMA 2018

Economic burden of cancer across the European Union: a population-based cost analysis.
Ramon Luengo-Fernandez, Jose Leal, Alastair Gray, Richard Sullivan. Lancet Oncol 2013

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S Carlino,[...]. N Engl J Med 2018

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
Jeffrey Weber, Mario Mandala, Michele Del Vecchio, Helen J Gogas, Ana M Arance, C Lance Cowey, Stéphane Dalle, Michael Schenker, Vanna Chiarion-Sileni, Ivan Marquez-Rodas,[...]. N Engl J Med 2017

Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha,[...]. N Engl J Med 2015

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study.
B Biesma, A N M Wymenga, A Vincent, O Dalesio, H J M Smit, J A Stigt, E F Smit, C L van Felius, J W G van Putten, J P J Slaets,[...]. Ann Oncol 2011

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.
Romain Corre, Laurent Greillier, Hervé Le Caër, Clarisse Audigier-Valette, Nathalie Baize, Henri Bérard, Lionel Falchero, Isabelle Monnet, Eric Dansin, Alain Vergnenègre,[...]. J Clin Oncol 2016

Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Cesare Gridelli, Lodovico Balducci, Fortunato Ciardiello, Massimo Di Maio, Enriqueta Felip, Corey Langer, Rogerio C Lilenbaum, Francesco Perrone, Suresh Senan, Filippo de Marinis. Clin Lung Cancer 2015

Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.
Jimmy Ruiz, Antonius A Miller, Janet A Tooze, Sandrine Crane, William J Petty, Ajeet Gajra, Heidi D Klepin. J Geriatr Oncol 2019

Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer.
Etienne Giroux Leprieur, Sylvie Labrune, Violaine Giraud, Thierry Gendry, Daniel Cobarzan, Thierry Chinet. Clin Lung Cancer 2012

Relevance of a Geriatric Assessment for Elderly Patients With Lung Cancer-A Systematic Review.
Karlijn J G Schulkes, Marije E Hamaker, Frederiek van den Bos, Leontine J R van Elden. Clin Lung Cancer 2016

Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.
Taofeek K Owonikoko, Camille C Ragin, Chandra P Belani, Ana B Oton, William E Gooding, Emanuela Taioli, Suresh S Ramalingam. J Clin Oncol 2007

[Geriatric assessment contribution to treatment decision-making in thoracic oncology].
V Aliamus, C Adam, M Druet-Cabanac, T Dantoine, A Vergnenegre. Rev Mal Respir 2011

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.
Supriya G Mohile, William Dale, Mark R Somerfield, Mara A Schonberg, Cynthia M Boyd, Peggy S Burhenn, Beverly Canin, Harvey Jay Cohen, Holly M Holmes, Judith O Hopkins,[...]. J Clin Oncol 2018

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale.
M D Miller, C F Paradis, P R Houck, S Mazumdar, J A Stack, A H Rifai, B Mulsant, C F Reynolds. Psychiatry Res 1992

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.
Elisabeth Quoix, Gérard Zalcman, Jean-Philippe Oster, Virginie Westeel, Eric Pichon, Armelle Lavolé, Jérôme Dauba, Didier Debieuvre, Pierre-Jean Souquet, Laurence Bigay-Game,[...]. Lancet 2011

Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: a nested case-control study.
Caroline Rivera, Pierre-Emmanuel Falcoz, Alain Bernard, Pascal A Thomas, Marcel Dahan. Chest 2011

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.
Hans Wildiers, Pieter Heeren, Martine Puts, Eva Topinkova, Maryska L G Janssen-Heijnen, Martine Extermann, Claire Falandry, Andrew Artz, Etienne Brain, Giuseppe Colloca,[...]. J Clin Oncol 2014

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.